To use all functions of this page, please activate cookies in your browser.
My watch list
my.chemeurope.com
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
FesoterodineThe antimuscarinic Fesoterodine is a drug developed by Schwarz Pharma AG to treat Overactive bladder syndrome.[1] It was recommended for approval by the European Medicines Agency in February 2007, but is not yet available for use.[citation needed] Additional recommended knowledgeReferences
|
| This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Fesoterodine". A list of authors is available in Wikipedia. |
Last viewed
- ‘Chemputer’ promises app-controlled revolution for drug production
- Merkwiller-Pechelbronn
- Diazole
- Anise
- Comment la vie peut-elle émerger dans un monde de minéraux ? - Le Conseil européen de la recherche (ERC) a attribué une subvention Synergie ERC au projet "Le rôle de la silice à l'aube de la vie sur notre planète" (PROTOS)
